News

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...
Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in ...
Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...
Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to treat atrial fibrillation ... s PulseSelect PFA device was approved ...
Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced ...
Catheter Ablation Devices for Atrial Fibrillation Market 2035, Driven by advanced devices, better clinical outcomes, and rising regulatory approvals.
The device won’t fix your irregular heartbeat (atrial fibrillation), but it does something just as important — it helps prevent strokes and lets you stop taking blood thinners for life.
MedLumics has raised another €18 million (around $22 million) to fund clinical trials of its optically-guided imaging system used to guide a surgical procedure for atrial fibrillation (AF ...
Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in ...
One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...
The global atrial fibrillation market is projected to witness robust growth over the next decade. In 2023, the market generated a substantial revenue of US$ 3,505.7 million and is estimated to achieve ...
Study supports the use of PFA as a first-line therapy to treat paroxysmal atrial fibrillation over cryoablation ... the pulmonary veins owing to the device design," they wrote, a theory supported ...